コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 the stroke (age, 69+/-8.4 years; 98% with an implantable defibrillator).
2 I studies, 31 had a pacemaker, and 24 had an implantable defibrillator.
3 July 2005, using the Medical Subject Heading implantable defibrillator.
4 or sudden death and are best treated with an implantable defibrillator.
5 eath, and they are sometimes treated with an implantable defibrillator.
6 nd a negative electrophysiology test with an implantable defibrillator.
7 ectrophysiology test who are treated with an implantable defibrillator.
8 for primary prevention of sudden death with implantable defibrillators.
9 ng 2 interventional studies in patients with implantable defibrillators.
10 le in all patients except those treated with implantable defibrillators.
11 cible tachycardia, except those treated with implantable defibrillators.
12 ardiomyopathy, congestive heart failure, and implantable defibrillators.
13 may include hospice care and inactivation of implantable defibrillators.
14 y, congestive heart failure, and status post implantable defibrillators.
15 ieve primary prevention of sudden death with implantable defibrillators.
16 arrhythmias with medications and the use of implantable defibrillators.
17 ontinued to receive amiodarone; 23 (45%) had implantable defibrillators.
18 incorporated in three commercially available implantable defibrillators.
19 readmission in patients with tiered-therapy implantable defibrillators.
20 ed to be within the range for amiodarone and implantable defibrillators.
21 ndomly assigned in a 3:2 ratio to receive an implantable defibrillator (742 patients) or conventional
23 diac reasons is common in patients receiving implantable defibrillators and is responsible for substa
26 select candidates to receive a prophylactic implantable defibrillator, and its accuracy has never be
27 ded by successes in the realm of pacemakers, implantable defibrillators, and ventricular assist devic
29 k patients with hypertrophic cardiomyopathy, implantable defibrillators are highly effective in termi
30 trials such as AVID (Antiarrhythmics Versus Implantable Defibrillators) are designed to determine th
31 antiarrhythmic therapy, including drugs and implantable defibrillators, as indicated by the results
32 genital heart disease is reviewed, including implantable defibrillators, atrial antitachycardia pacem
36 of patients from the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study Registry to dete
38 Screening for the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial identified patie
39 ic VT followed in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial through December
41 logically guided antiarrhythmic therapy with implantable defibrillators, but not with antiarrhythmic
42 tion therapy (CRT) alone or combined with an implantable defibrillator (CRT-D) has been shown to impr
45 (n=20) during shocks applied with the use of implantable defibrillator electrodes during the refracto
47 ained ventricular arrhythmia treated with an implantable defibrillator, freedom from appropriate defi
50 panding clinical indications, pacemakers and implantable defibrillators have become increasingly impo
51 story and disease course for many, including implantable defibrillators, heart transplant, external d
52 dia, ventricular fibrillation or appropriate implantable defibrillator (ICD) therapy, and the seconda
55 hmic treatment strategy, including drugs and implantable defibrillators (ICDs), guided by electrophys
56 the Medical Subject Headings defibrillators, implantable; defibrillators, implantable/adverse effects
57 guide the use of implantable pacemakers and implantable defibrillators in patients who have hypertro
58 did not demonstrate mortality reduction with implantable defibrillators in patients with recent myoca
61 1), PV (n = 29), or ICED (n = 30) (automatic implantable defibrillator [n = 11] or pacemaker [n = 19]
63 al was designed to evaluate the effect of an implantable defibrillator on survival in such patients.
64 000, through October 31, 2016, for the terms implantable defibrillator OR implantable cardioverter de
65 ation for anticoagulation with heparin after implantable defibrillator or pacemaker implantation were
67 icant ventricular arrhythmia, indication for implantable defibrillator, or new or worsening HF at 6-m
68 face potential mappings were obtained during implantable defibrillator pacing, catheter pacing from 7
69 2 percent fatal adverse effects (potentially implantable defibrillators) saves 1 life for every 14 pa
70 t hospitalization and, when combined with an implantable defibrillator, significantly reduces mortali
71 le Defibrillators Study (AVID), the Canadian Implantable Defibrillator Study (CIDS), and the Cardiac
72 trials, including the Antiarrhythmics Versus Implantable Defibrillators Study (AVID), the Canadian Im
73 ients enrolled in the Antiarrhythmics Versus Implantable Defibrillators Study were used to create a h
74 dioverter-defibrillator (S-ICD) is the first implantable defibrillator that avoids placing electrodes
76 the current success of ablative therapy and implantable defibrillators, the need is still pressing f
82 , our current clinical practice is to use an implantable defibrillator to treat an initial episode of
83 reatment strategies are available, including implantable defibrillators to prevent sudden death, drug
84 urvival data from the Antiarrhythmics Versus Implantable Defibrillators trail were used to calculate
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。